Skip to main content
. 2020 May 25;14:24–31. doi: 10.1016/j.phro.2020.04.002

Table 2.

Statistics of the dose comparison of the thirty patients in the test set for the sCT trained on all the anatomical site together. The values are reported as percentage mean±1σ and range [min; max].

sCT vs rCT CT vs rCT
Sites DDsCTa γ3%,3mmb γ2%,2mmc DDrCTd γ3%,3mmb γ2%,2mmc
[%] [%] [%] [%] [%] [%]
Head-and-neck   0.1±0.5[-0.8;0.7] 99.3±0.4[98.7;99.9] 97.8±1[95.8;99.2] 0.9±1.1[-1.8;2.0] 98.7±1[96.4;99.7] 96±3[90;99]
Lung 0.2±0.9[-1.3;1.8] 98.2±1[96;100] 94.9±3[89;98] -0.1±1.5[-2.6;3.0] 98.0±1.7[95;100] 94±4[86;99]
Breast 0.1±0.4[-0.5;0.8] 97±4[86;100] 92±8[71;98] -0.3±0.8[-1.7;0.7] 98±3[91;100] 93±6[80;98]

aDDsCT=sCT-rCTrCT·100 on dose >90% of the prescribed dose.

b Pass rates of γ3%,3mm on dose >10% of the prescribed dose.

c Pass rates of γ2%,2mm on dose >10% of the prescribed dose.

dDDrCT=rCT-CTCT·100 on dose >90% of the prescribed dose.